AI START-UP TO APPLY ITS TECH TO IMPROVE IVF OUTCOMES

START-UP Life Whisperer will partner with the Monash IVF Group (ASX: MVF) and its subsidiary Repromed to apply its artificial intelligence tech in the selection of healthy embryos.

The agreement will give Life Whisperer access to thousands of images and embryologist expertise to apply Life Whisperer's AI-driven technology for non-invasive embryo image analysis and embryo selection.

Professor Michelle Lane, Science and Innovation Manager at Monash IVF, says the ultimate goal is to improve outcomes for IVF couples.

"The technology, when scientifically validated, will assist our scientists to select viable embryos for implantation, and ultimately increase birth outcomes for our patients," says Lane.

Repromed General Manager, Dr Hamish Hamilton, says the partnership will give patients a higher chance of being able to conceive via IVF.

"Repromed is always innovating and using cutting edge technologies that are evidence based to ensure we provide our patients the greatest chance of successfully having children," says Hamilton.

Life Whisperer was co-founded by Dr Jonathan Hall, Dr Michelle Perugini, and Dr Don Perugini, in 2016 with aims to improve the outcomes of IVF treatment.

The Perugini's have significant experience in AI technologies, having founded Presagen - a behavioural AI application created to automate complex human-centric tasks in business.

Michelle Perugini says Life Whisperer's success will hopefully stem the growing rates of infertility.

"With infertility rates growing globally, the industry is crying out for technologies that can improve the successful outcomes for couples wanting to have children," says Perugini.

"Life Whisperer aims to help those couples by applying state of the art computer science and AI technology to give clinics the best possible edge in selecting the best embryo for IVF."

Life Whisperer aims to deliver the AI technology to clinics around the world via a web-based application, according to Michelle Perugini.

"Scientists currently take images of embryos and visually assess their viability," says Perugini.

"Our evidence-based approach will allow the embryologist to drag and drop that image into a web based portal, and receive an assessment of the viability of the embryo to support their decision of which embryo to implant."

"The Monash IVF and Repromed partnership is an important milestone on Life Whisperer's journey to commercialise the technology globally."

Business News Australia